RG
Rajshree Gilada
About Rajshree Gilada
Data last updated:
Rajshree Gilada is a Director at Shankarlal Gilada & Sons Private Limited (since 2010), Director at Denvia Pharmaceuticals Private Limited (since 2026) and Partner at Manasvita Developers And Builders Llp (since 2023). The companies operate in Financial Services. The largest current company by reported revenue is Shankarlal Gilada & Sons Private Limited at ₹5.38 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Shankarlal Gilada & Sons Private Limited U67120KA1999PTC025546 | Director | 08 Mar 2010 | 1999 | ₹5.38 Cr (FY 2024) | Active |
 Denvia Pharmaceuticals Private Limited U21000KA2026PTC226293 | Director | 18 Aug 2026 | 2026 | Active | |
| Partner | 26 Dec 2023 | 2023 | Active |
Board colleagues of Rajshree Gilada
| Name | DIN | Company | Designation |
|---|---|---|---|
| Bindu Rajagopal Gilada | 00392976 | Shankarlal Gilada & Sons Private Limited | Director |
| Rajgopal Shankarlal Gilada | 00307829 | Shankarlal Gilada & Sons Private Limited | Director |
| Sampatkumar Shankarlal Gilada | 02144736 | Shankarlal Gilada & Sons Private Limited , Manasvita Developers And Builders Llp | Director |
| Sangeeta Sampathkumar Gilada | 02293069 | Shankarlal Gilada & Sons Private Limited | Director |
| Arun Kumar Veerashetty Beknal | 11898482 | Denvia Pharmaceuticals Private Limited | Director |
| Dandin Vishwanath | 11898481 | Denvia Pharmaceuticals Private Limited | Director |
| Ravindrakumar Beknal | 11898483 | Denvia Pharmaceuticals Private Limited | Director |
| Sarang Mehta | 07702262 | Denvia Pharmaceuticals Private Limited | Director |
| Vedant Tapadiya | 10337314 | Manasvita Developers And Builders Llp | Designated Partner |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Rajshree Gilada
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Rajshree Gilada
Rajshree Gilada currently holds 3 directorships: Shankarlal Gilada & Sons Private Limited (Director, since 08 Mar 2010, revenue ₹5.38 Cr (FY 2024)); Denvia Pharmaceuticals Private Limited (Director, since 18 Aug 2026); Manasvita Developers And Builders Llp (Partner, since 26 Dec 2023).
Rajshree Gilada was first appointed on 08 Mar 2010 as Director at Shankarlal Gilada & Sons Private Limited. The most recent appointment on record is 18 Aug 2026 at Denvia Pharmaceuticals Private Limited.
The current boards of Rajshree Gilada's companies include Bindu Rajagopal Gilada (Shankarlal Gilada & Sons Private Limited), Rajgopal Shankarlal Gilada (Shankarlal Gilada & Sons Private Limited), Sampatkumar Shankarlal Gilada (Shankarlal Gilada & Sons Private Limited), Sangeeta Sampathkumar Gilada (Shankarlal Gilada & Sons Private Limited), Arun Kumar Veerashetty Beknal (Denvia Pharmaceuticals Private Limited), Dandin Vishwanath (Denvia Pharmaceuticals Private Limited), among others.